These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10575334)

  • 41. A comparison of six different ways of expressing the bronchodilating response in asthma and COPD; reproducibility and dependence of prebronchodilator FEV1.
    Dompeling E; van Schayck CP; Molema J; Akkermans R; Folgering H; van Grunsven PM; van Weel C
    Eur Respir J; 1992 Sep; 5(8):975-81. PubMed ID: 1426206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Smoking and obstructive lung dysfunction in persons with chronic spinal cord injury.
    Linn WS; Spungen AM; Gong H; Bauman WA; Adkins RH; Waters RL
    J Spinal Cord Med; 2003; 26(1):28-35. PubMed ID: 12830966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist.
    Cazzola M; Boveri B; Carlucci P; Santus P; DiMarco F; Centanni S; Allegra L
    Pulm Pharmacol Ther; 2000; 13(6):301-5. PubMed ID: 11061985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
    Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
    Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality of life measured by the St George's Respiratory Questionnaire and spirometry.
    Weatherall M; Marsh S; Shirtcliffe P; Williams M; Travers J; Beasley R
    Eur Respir J; 2009 May; 33(5):1025-30. PubMed ID: 19164350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of COPD progression based on spirometry and exercise capacity.
    Trzaska-Sobczak M; Brożek G; Farnik M; Pierzchała W
    Pneumonol Alergol Pol; 2013; 81(4):288-93. PubMed ID: 23744163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study.
    Wise RA; Kanner RE; Lindgren P; Connett JE; Altose MD; Enright PL; Tashkin DP;
    Chest; 2003 Aug; 124(2):449-58. PubMed ID: 12907528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An evaluation of nebulized levalbuterol in stable COPD.
    Datta D; Vitale A; Lahiri B; ZuWallack R
    Chest; 2003 Sep; 124(3):844-9. PubMed ID: 12970007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.
    Pauwels RA; Löfdahl CG; Laitinen LA; Schouten JP; Postma DS; Pride NB; Ohlsson SV
    N Engl J Med; 1999 Jun; 340(25):1948-53. PubMed ID: 10379018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atherosclerotic plaques in the internal carotid artery and associations with lung function assessed by different methods.
    Frantz S; Nihlén U; Dencker M; Engström G; Löfdahl CG; Wollmer P
    Clin Physiol Funct Imaging; 2012 Mar; 32(2):120-5. PubMed ID: 22296632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relation between duration of smoking cessation and bronchial inflammation in COPD.
    Lapperre TS; Postma DS; Gosman MM; Snoeck-Stroband JB; ten Hacken NH; Hiemstra PS; Timens W; Sterk PJ; Mauad T
    Thorax; 2006 Feb; 61(2):115-21. PubMed ID: 16055612
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study.
    Simmons MS; Connett JE; Nides MA; Lindgren PG; Kleerup EC; Murray RP; Bjornson WM; Tashkin DP
    Eur Respir J; 2005 Jun; 25(6):1011-7. PubMed ID: 15929955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family.
    Polverino F; Baraldo S; Bazzan E; Agostini S; Turato G; Lunardi F; Balestro E; Damin M; Papi A; Maestrelli P; Calabrese F; Saetta M
    Am J Respir Crit Care Med; 2010 Oct; 182(8):1011-9. PubMed ID: 20581172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
    Watson L; Vonk JM; Löfdahl CG; Pride NB; Pauwels RA; Laitinen LA; Schouten JP; Postma DS;
    Respir Med; 2006 Apr; 100(4):746-53. PubMed ID: 16199147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care.
    O'Brien C; Guest PJ; Hill SL; Stockley RA
    Thorax; 2000 Aug; 55(8):635-42. PubMed ID: 10899238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial.
    Simmons MS; Nides MA; Rand CS; Wise RA; Tashkin DP
    Chest; 2000 Aug; 118(2):290-5. PubMed ID: 10936115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
    Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
    Lung; 2006; 184(4):217-22. PubMed ID: 17006748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.